Abreu, M. M
~ 24000  Ergebnisse:
Personensuche X
?
3

A18 EARLY LIFE EXPOSURE TO PARENTAL CROHN'S DISEASE IS ASSO..:

Bushra, M ; Shao, J ; Qiu, L...
Journal of the Canadian Association of Gastroenterology.  7 (2024)  Supplement_1 - p. 10-10 , 2024
 
?
 
?
7

OP15 Efficacy of ustekinumab for Ulcerative Colitis through..:

Danese, S ; Afif, W ; Abreu, M...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i19-i20 , 2023
 
?
8

Production of Tcc+ in heavy ion collisions:

Abreu, L.M. ; Navarra, F.S. ; Nielsen, M..
Nuclear and Particle Physics Proceedings.  324-329 (2023)  - p. 40-43 , 2023
 
?
10

A185 SUSTAINED SYMPTOM CONTROL WITH MIRIKIZUMAB IN PATIENTS..:

Dignass, A ; Danese, S ; Matsuoka, K...
Journal of the Canadian Association of Gastroenterology.  6 (2023)  Supplement_1 - p. 29-31 , 2023
 
?
 
?
12

A184 EARLY SYMPTOM CONTROL WITH MIRIKIZUMAB IN PATIENTS WIT..:

Danese, S ; Dignass, A ; Matsuoka, K...
Journal of the Canadian Association of Gastroenterology.  6 (2023)  Supplement_1 - p. 28-29 , 2023
 
?
14

OP29 Peri-natal exposure to parental Crohn's disease is ass..:

Lee Dr., S H ; Qiu, L ; Olivera, P A...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i40-i41 , 2023
 
?
15

OP39 Safety of ustekinumab in IBD: Final pooled long-term s..:

Ghosh, S ; Feagan, B ; Ott, E...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i55-i56 , 2023
 
1-15